Clostridium Difficile (C.Diff.) Implementing Strategies for - PowerPoint PPT Presentation

Dec 24, 2022 •379 likes •504 views

Clostridium Difficile (C.Diff.) Implementing Strategies for Improvement TCPS CDI Performance Includes all TCPS Partner Hospitals Topic 2016 2017 Events SIR Hospital Events SIR Hospital Outliers Outliers C.DIFF. 2,169 0.879 9

Clostridium Difficile (C.Diff.) Implementing Strategies for Improvement
TCPS CDI Performance Includes all TCPS Partner Hospitals Topic 2016 2017 Events SIR Hospital Events SIR Hospital Outliers Outliers C.DIFF. 2,169 0.879 9 1,983 0.832 4 Data Source: NHSN as of 6/12/2018 This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.
HRET CDI Sprint Two participating facilities May 22 – July 12, 2018
HRET CDI Sprint • Self-assessment with feedback from HRET • Auditing and RCA tools • Coaching from SHA • Webinars based on facility size for sharing of successful strategies
Lessons Learned Diagnostic Lab Stewardship Stewardship
Lessons Learned Diagnostic Stewardship
Lessons Learned Lab Stewardship

Download Presentation

Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

Clostridium difficile Infection (CDI) Gail Bennett, RN, MSN, CIC 1 Clostridium difficile

Clostridium difficile Infection (CDI) Gail Bennett, RN, MSN, CIC 1 Clostridium difficile (C.difficile) Antibiotic induced diarrhea Can cause pseudomembranous colitis Most common cause of acute infectious diarrhea in nursing homes

621 views • 50 slides

11/5/2015 Some history first The Epidemiology of Clostridium difficile Clostridium

11/5/2015 Some history first The Epidemiology of Clostridium difficile Clostridium difficile , a spore-forming gram-positive (i.e., thick cell wall) anaerobic bacillus, was initially detected in the fecal flora of healthy newborns in D A

250 views • 3 slides

IMM-529 for the prevention and treatment of Clostridium difficile infections Clostridium

IMM-529 for the prevention and treatment of Clostridium difficile infections Clostridium difficile http://www.nlm.nih.gov/medlineplus/images/clostridiumdifficile.jpg Gram positive, spore forming anaerobe Major nosocomial pathogen

929 views • 45 slides

Impact of C. difficile in Canada What is Clostridium difficile ? Spore-forming bacteria

Antimicrobial Stewardship Backgrounder: Clostridium difficile Infection (CDI) Susan Fryters, BScPharm, ACPR Antimicrobial Utilization/Infectious Diseases Pharmacist Alberta Health Services Susan.Fryters@albertahealthservices.ca Effective, Safe,

308 views • 4 slides

Multidrug-Resistant Organism (MDRO) and Clostridium difficile -Associated Disease (CDAD) Module

Multidrug-Resistant Organism (MDRO) and Clostridium difficile -Associated Disease (CDAD) Module Training Course Section: C. difficile Infection Surveillance and C. difficile LabID Event Reporting 1 C. Difficile Infection Target Audience This

842 views • 52 slides

for Clostridium difficile Janel Liane Cala, RPh Medical Center Hospital Objectives Review

Bezlotoxumab (Zinplava) as Adjunct Treatment for Clostridium difficile Janel Liane Cala, RPh Medical Center Hospital Objectives Review pathophysiology, risk factors, prevention, and treatment options of Clostridium difficile Infection (CDI)

662 views • 31 slides

Disclosures Consultant: Genentech Clostridium difficile infection Sarah Doernberg, MD, MAS

Disclosures Consultant: Genentech Clostridium difficile infection Sarah Doernberg, MD, MAS Associate Professor, Division of Infectious Diseases Medical Director of Adult Antimicrobial Stewardship Some controversy Outline Clostridium versus

518 views • 15 slides

Clostridium difficile infections Contrast diagnostic testing for CDI Describe treatment

Objectives Recognize patients at risk for C. difficile infection (CDI) Clostridium difficile infections Contrast diagnostic testing for CDI Describe treatment strategies for mild, severe, and fulminant CDI and fecal transplant

371 views • 15 slides

Improving risk prediction of Clostridium Difficile Infection using temporal event-pairs Mauricio

Improving risk prediction of Clostridium Difficile Infection using temporal event-pairs Mauricio Monsalve Computational Epidemiology (compepi) group The University of Iowa A A T T A G A G LANCE LANCE Clostridium Difficile Infection (CDI)

290 views • 27 slides

The Epidemiology of Clostridium difficile D A N I E L S A M A N , D R P H , M P H R E S E A

The Epidemiology of Clostridium difficile D A N I E L S A M A N , D R P H , M P H R E S E A R C H S C I E N T I S T E S S E N T I A I N S T I T U T E O F R U R A L H E A L T H Some history first Clostridium difficile , a

419 views • 18 slides

Nosocomial Clostridium difficile Infection (CDI): Things Are Not Always As They Seem Angela

Nosocomial Clostridium difficile Infection (CDI): Things Are Not Always As They Seem Angela Wigmore, K. Suh, N. Bruce, G. Garber, C. Chambers, Liz Van Horne, V. Allen, C. Egan, K. Stockton, V. Roth Disclosure None of the authors on this

382 views • 16 slides

Clostridium difficile infection (CDI) in the Pediatric Population Childrens Hospitals FHA

Clostridium difficile infection (CDI) in the Pediatric Population Childrens Hospitals FHA Hospital Improvement Innovation Network (HIIN) May 1, 2018 Overview Welcome Back Review of the data Interactive Presentation by Linda

1.05k views • 69 slides

Clostridium difficile infection Sarah Doernberg, MD, MAS Associate Professor, Division of

Clostridium difficile infection Sarah Doernberg, MD, MAS Associate Professor, Division of Infectious Diseases Medical Director of Adult Antimicrobial Stewardship Disclosures Consultant: Genentech, Basilea Pharmaceutica 1 | [footer text

542 views • 29 slides

Clostridium difficile Sarah Doernberg, MD, MAS Assistant professor and Medical Director of

Clostridium difficile Sarah Doernberg, MD, MAS Assistant professor and Medical Director of Antimicrobial Stewardship Division of Infectious Diseases, UCSF 2.19,2018 Outline Brief background and epidemiology Diagnosis

618 views • 30 slides

Antibiotic stewardship and Clostridium difficile infection Sarah Doernberg, MD, MAS Associate

Antibiotic stewardship and Clostridium difficile infection Sarah Doernberg, MD, MAS Associate Professor, Division of Infectious Diseases Medical Director of Adult Antimicrobial Stewardship Disclosures Consultant: Genentech, Actelion 1 |

456 views • 45 slides

Kansas HEN 2.0 Collaborative Meeting November 18, 2015 Reducing Clostridium Difficile and Improving

Kansas HEN 2.0 Collaborative Meeting November 18, 2015 Reducing Clostridium Difficile and Improving Antimicrobial Stewardship WHATS THE POOPMMM...SCOOP?! Cheryl Ruble, MS, RN CNS Improvement Advisor, Cynosure Health 1 2014 Silver Award

486 views • 27 slides

Objectives Introducing the Florida Department of Healths Health Care-Associated Infection

Chasing Zero Infections - Connecting the Dots Thursday, May 25, 2017 to Reduce Patient Harm: Hot Topics in Infection Prevention and Stewardship The Big Picture: Statewide Program Targeting Clostridium difficile Infection and Establishing a

471 views • 14 slides

Clostridium difficile Disclosures: Consultant for Actelion, prior research studies with Cerexa,

Clostridium difficile Disclosures: Consultant for Actelion, prior research studies with Cerexa, Merck, Cubist Sarah Doernberg, MD, MAS Assistant Professor, University of California, San Francisco Medical Director, Adult Antimicrobial

498 views • 15 slides

Welcome! Denver Marijuana Industry Meeting De Hosted by: Denver Environmental Health Public

Welcome! Denver Marijuana Industry Meeting De Hosted by: Denver Environmental Health Public Health Inspections Division Denvergov.org/HealthInspections 9/12/17 lth department Agenda Introduction PHI overview Public health

451 views • 18 slides

Partnership Regional Workshops Checking in Moving Forward 1 Checking in Website and

C. Difficile Prevention Partnership Regional Workshops Checking in Moving Forward 1 Checking in Website and toolkit Measurement Feedback form Questions? What else do you need? 2 Table Talk Since beginning this work

581 views • 30 slides

Age Agent Updat Update & Tr Training Agenda OR Update Commercial Activity

Age Agent Updat Update & Tr Training Agenda OR Update Commercial Activity Pricing Update Marketing Support New Product Launch Indigo-Clean Downlight Indigo-Clean MEIC Series Questions Kenall Confidential 2

365 views • 24 slides

Progress and impact in Australia and abroad The impact of (our) . health services research

National performance reporting: Progress and impact in Australia and abroad The impact of (our) . health services research About the Performance Authority www.nhpa.gov.au About Hospital Performance reports

570 views • 30 slides

Combining SAXS and crystallography Rob Meijers EMBL Hamburg Outstation, Germany Stories of

Combining SAXS and crystallography Rob Meijers EMBL Hamburg Outstation, Germany Stories of SAXS and MX A dimer that didnt add up A trimer that didnt add up A disordered guidance cue Haydyn Mertens 2 22/10/16 The before

916 views • 44 slides

Performance Measurement Work Group 10/21/2016 Meeting RY 2019 Maryland Hospital Acquired

Performance Measurement Work Group 10/21/2016 Meeting RY 2019 Maryland Hospital Acquired Conditions (MHAC) RY 2019 MHAC Update Considerations Update to PPC Grouper Version (currently assessing) Revise base period to October

650 views • 29 slides